0QF:ETR
Moderna Inc
167,50 €
arrow_upward
+1,44%(+2,38) 1 p
1. okt, 09:36:57 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 0QF põhistatistika genereerimine…
Ava
168,10 €
Kõrge
168,48 €
Madal
167,36 €
Turu kapit.
76,88 mld
Keskm. maht
38,89 tuh
Maht
1,23 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Ava
168,10 €
Kõrge
168,48 €
Madal
167,36 €
Turu kapit.
76,88 mld
Keskm. maht
38,89 tuh
Maht
1,23 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Barron's
·
10 tunni eest
Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today’s Market
Investor's Business Daily
·
11 tunni eest
After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst
Investopedia
·
12 tunni eest
Moderna Stock Slumps as Citi Says It’s Time to Sell After 500% Rally This Year
Benzinga
·
12 tunni eest
Moderna Shares Reverse Weakness, Rise Over 3% After Key Trading Signal
Profiil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
Teave üksuse Moderna Inc kohta